A detailed history of Nisa Investment Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 554,950 shares of BMY stock, worth $32.1 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
554,950
Previous 509,789 8.86%
Holding current value
$32.1 Million
Previous $21.2 Million 35.65%
% of portfolio
0.17%
Previous 0.13%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$39.66 - $51.75 $1.79 Million - $2.34 Million
45,161 Added 8.86%
554,950 $28.7 Million
Q2 2024

Jul 19, 2024

BUY
$40.25 - $52.99 $756,941 - $996,529
18,806 Added 3.83%
509,789 $21.2 Million
Q1 2024

May 01, 2024

SELL
$47.98 - $54.4 $3.3 Million - $3.74 Million
-68,678 Reduced 12.27%
490,983 $26.6 Million
Q4 2023

Jan 25, 2024

SELL
$48.48 - $57.85 $2.26 Million - $2.69 Million
-46,526 Reduced 7.68%
559,661 $28.7 Million
Q3 2023

Nov 02, 2023

SELL
$57.89 - $64.73 $2.87 Million - $3.21 Million
-49,567 Reduced 7.56%
606,187 $35.2 Million
Q2 2023

Aug 11, 2023

BUY
$63.71 - $70.74 $484,004 - $537,411
7,597 Added 1.17%
655,754 $41.9 Million
Q1 2023

May 02, 2023

SELL
$65.71 - $74.53 $1.47 Million - $1.67 Million
-22,398 Reduced 3.34%
648,157 $44.9 Million
Q4 2022

Feb 02, 2023

SELL
$68.48 - $81.09 $1.45 Million - $1.71 Million
-21,146 Reduced 3.06%
670,555 $48.2 Million
Q3 2022

Nov 07, 2022

BUY
$0.13 - $76.84 $1,151 - $680,879
8,861 Added 1.3%
691,701 $49.3 Million
Q2 2022

Aug 03, 2022

BUY
$72.62 - $79.98 $2.08 Million - $2.29 Million
28,622 Added 4.37%
682,840 $52.6 Million
Q1 2022

Apr 29, 2022

SELL
$61.48 - $73.72 $15.1 Million - $18.1 Million
-245,346 Reduced 27.27%
654,218 $47.8 Million
Q4 2021

Feb 03, 2022

BUY
$53.63 - $62.52 $11.9 Million - $13.9 Million
222,312 Added 32.83%
899,564 $58.4 Million
Q3 2021

Oct 18, 2021

BUY
$59.17 - $69.31 $1.19 Million - $1.4 Million
20,156 Added 3.07%
677,252 $40.1 Million
Q2 2021

Aug 06, 2021

SELL
$61.91 - $67.42 $746,882 - $813,354
-12,064 Reduced 1.8%
657,096 $43.9 Million
Q1 2021

Apr 26, 2021

BUY
$59.34 - $66.74 $1.91 Million - $2.15 Million
32,150 Added 5.05%
669,160 $42.2 Million
Q4 2020

Jan 25, 2021

SELL
$57.74 - $65.43 $1.18 Million - $1.34 Million
-20,441 Reduced 3.11%
637,010 $39.5 Million
Q3 2020

Oct 20, 2020

SELL
$57.43 - $63.64 $2.64 Million - $2.92 Million
-45,930 Reduced 6.53%
657,451 $39.6 Million
Q2 2020

Jul 27, 2020

SELL
$54.82 - $64.09 $4.19 Million - $4.9 Million
-76,397 Reduced 9.8%
703,381 $41.4 Million
Q1 2020

Apr 17, 2020

SELL
$46.4 - $67.43 $5.4 Million - $7.85 Million
-116,347 Reduced 12.98%
779,778 $43.5 Million
Q4 2019

Jan 17, 2020

BUY
$49.21 - $64.19 $14.8 Million - $19.3 Million
300,785 Added 50.52%
896,125 $57.5 Million
Q3 2019

Oct 17, 2019

SELL
$42.77 - $50.71 $166,546 - $197,464
-3,894 Reduced 0.65%
595,340 $30.2 Million
Q2 2019

Jul 12, 2019

BUY
$44.62 - $49.34 $637,887 - $705,364
14,296 Added 2.44%
599,234 $27.2 Million
Q1 2019

Apr 17, 2019

SELL
$45.12 - $53.8 $443,168 - $528,423
-9,822 Reduced 1.65%
584,938 $27.9 Million
Q4 2018

Jan 17, 2019

BUY
$48.76 - $63.23 $604,770 - $784,241
12,403 Added 2.13%
594,760 $30.9 Million
Q3 2018

Oct 16, 2018

BUY
$55.19 - $62.25 $137,588 - $155,189
2,493 Added 0.43%
582,357 $36.2 Million
Q2 2018

Jul 19, 2018

SELL
$50.53 - $62.98 $1.72 Million - $2.14 Million
-33,957 Reduced 5.53%
579,864 $32.1 Million
Q1 2018

Apr 10, 2018

BUY
$59.92 - $68.98 $345,318 - $397,531
5,763 Added 0.95%
613,821 $39.2 Million
Q4 2017

Jan 12, 2018

BUY
$59.94 - $65.35 $1.62 Million - $1.77 Million
27,053 Added 4.66%
608,058 $37.3 Million
Q3 2017

Oct 13, 2017

BUY
$55.23 - $63.74 $32.1 Million - $37 Million
581,005
581,005 $37 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.